[Skip to content]

tab rollover pre-load tab rollover pre-load tab rollover pre-load tab rollover pre-load tab rollover pre-load tab rollover pre-load
Friday 19 July 2019
Salford News Header Montage
Latest News:
RSS icon
Search
.
[ Zoom ]
Salford Royal urology team
The Salford Royal Urology team

Pioneering procedure speeding up the diagnosis and treatment for cancer patients

Salford Royal has become the first Trust in Greater Manchester to carry out a procedure that is speeding up the diagnosis and treatment of cancer patients.

 

Transperineal prostate biopsies – biopsies to look for cancer cells in the prostate – are usually conducted under general anaesthetic in the operating theatre but thanks to new developments in technology, the procedure can now be carried out under local anaesthetic in the clinic enabling a safer, more accurate and rapid diagnosis.

 

The alternative biopsy technique which has been around for two decades – transrectal prostate biopsy – is associated with a 5% risk of admission to hospital with infection.

 

Mr Satish Maddineni, Consultant Urological Surgeon, and the urology team at Salford Royal have now carried out transperineal prostate biopsies under local anaesthetic in the outpatients department.

 

Patients can now be seen in a 30 minute clinic appointment rather than having to attend pre-op assessments and wait for available theatre slots which can add significant delays.

 

The new procedure is for patients on a suspected prostate cancer pathway that have not yet received a diagnosis.

 

Professor Dave Shackley, Director of Greater Manchester Cancer, said: “This development is fantastic news for patients in Greater Manchester who may be facing a possible diagnosis of prostate cancer.

 

“Greater Manchester Cancer is committed to improving outcomes and experience for our patients; this new procedure not only offers some patients the choice to avoid a general anaesthetic procedure, but may also in many cases support a reduction in the time to diagnosis and treatment, and reduce complications.”

 

Over time it is hoped all patients with suspected prostate cancer can be offered this procedure.

 

Mr Maddineni said: “This is a huge step forward in the diagnosis of prostate cancer for the patients of Greater Manchester. It is a more accurate, cleaner and safer way to diagnose patients with suspected cancer and significantly reduces the risks of urinary tract infections and sepsis.”